EPCAM and neoplasm: The hijacking of sinusoidal blood vessels by tumor cells in RHGP lesions has been reported in both preclinical and clinical CRCLM cases (9, 11), and EpCAM+ tumor cells infiltrating the sinusoidal blood vessels are considered to indicate vessel co-option (8, 9, 11).